Afaf A. Al Ansari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Afaf A. Al Ansari has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Hanan Farghaly
Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, QAT
2 shared publications - A.A. Al Rashid
Clinical Imaging Department, Hamad General Hospital, Hamad Medical Corporation, Doha, 3050, Qatar
1 shared publication - A.M.H. Alobadli
Clinical Imaging Department, Hamad Medical Corporation, Doha, 3050, Qatar
1 shared publication - Aalaa Kambal
Clinical Imaging Department, Hamad General Hospital, Hamad Medical Corporation, Doha, 3050, Qatar
1 shared publication - Abdelrahman Abdelaal
Department of General Surgery, Hamad General Hospital, Doha, Qatar
1 shared publication - Adham Darweesh
Clinical Imaging Department, Hamad General Hospital, Hamad Medical Corporation, Doha, 3050, Qatar
1 shared publication
Latest Publications
- Open Access
- 30 October 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107148
Utility of diffusion-weighted signal intensity ratio measurements for predicting malignancy in adnexal mass lesions and its comparison with ORADS MRI scoring: Can an abbreviated MRI protocol predict malignancy accurately?
- 30 October 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107148
Open AccessUtility of diffusion-weighted signal intensity ratio measurements for predicting malignancy in adnexal mass lesions and its comparison with ORADS MRI scoring: Can an abbreviated MRI protocol predict malignancy accurately?
- Open Access
- 1 May 2020
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 32, 100556
Management of acute haemorrhage following chemotherapy for invasive molar pregnancy by embolization and conservative fertility-sparing surgery
- 1 May 2020
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 32, 100556
Open AccessManagement of acute haemorrhage following chemotherapy for invasive molar pregnancy by embolization and conservative fertility-sparing surgery
- Open Access
- 24 July 2018
- Published by Springer Nature in Thyroid Research
- Vol. 11 (1) , 10
The largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature
Malignant struma ovarii (MSO) is a very rare, germ cell tumor of the ovary, histologically identical to differentiated thyroid cancers. Struma ovarii (SO) is difficult to diagnose on clinical basis or imaging and is mostly discovered incidentally, with few published cases in the literature. A 42-year old primiparous woman presented with abdominal pain and midline pelvic palpable firm mass arising from the pelvis. Imaging showed pelvic solid cystic mass. Total abdominal hysterectomy, bilateral salpingo-oopherectomy (TAH BSO) and infracolic omentectomy were performed. Histopathology revealed left ovary papillary thyroid carcinoma (PTC) arising in SO (11 cm) and metastatic papillary thyroid carcinoma in the right ovary. Thyroid functions tests were all normal, ultrasound thyroid showed two complex nodules in the left thyroid lobe. Total thyroidectomy was decided, but the patient refused further surgical management and was lost to follow up as she left the country. We undertook a comprehensive literature search, and MSO and thyroid management data from 23 additional publications were analyzed and tabulated. This PTC MSO is probably the largest reported in the literature. Among the different surgeries for MSO, TAH + BSO appears to have the best clinical outcome. However, unilateral salpingo-oopherectomy/ unilateral oophorectomy and bilateral salpingo-oopherectomy also seem effective. Ovarian cystectomy alone seems associated with higher recurrence. There remains no consensus on the associations between MSO tumor size and potential extent of metastasis, and about the management of thyroid gland. However, surveillance and thyroid gland work up to detect concurrent thyroid cancer are recommended.
- 24 July 2018
- Published by Springer Nature in Thyroid Research
- Vol. 11 (1) , 10
Open AccessThe largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature
Malignant struma ovarii (MSO) is a very rare, germ cell tumor of the ovary, histologically identical to differentiated thyroid cancers. Struma ovarii (SO) is difficult to diagnose on clinical basis or imaging and is mostly discovered incidentally, with few published cases in the literature. A 42-year old primiparous woman presented with abdominal pain and midline pelvic palpable firm mass arising from the pelvis. Imaging showed pelvic solid cystic mass. Total abdominal hysterectomy, bilateral salpingo-oopherectomy (TAH BSO) and infracolic omentectomy were performed. Histopathology revealed left ovary papillary thyroid carcinoma (PTC) arising in SO (11 cm) and metastatic papillary thyroid carcinoma in the right ovary. Thyroid functions tests were all normal, ultrasound thyroid showed two complex nodules in the left thyroid lobe. Total thyroidectomy was decided, but the patient refused further surgical management and was lost to follow up as she left the country. We undertook a comprehensive literature search, and MSO and thyroid management data from 23 additional publications were analyzed and tabulated. This PTC MSO is probably the largest reported in the literature. Among the different surgeries for MSO, TAH + BSO appears to have the best clinical outcome. However, unilateral salpingo-oopherectomy/ unilateral oophorectomy and bilateral salpingo-oopherectomy also seem effective. Ovarian cystectomy alone seems associated with higher recurrence. There remains no consensus on the associations between MSO tumor size and potential extent of metastasis, and about the management of thyroid gland. However, surveillance and thyroid gland work up to detect concurrent thyroid cancer are recommended.